No products in the cart.
Cervical Cancer Antibodies
Cervical cancers are a relatively rare diagnosed cancer in the United States, with about 0.7% of new cancer cases classified as cervical, contributing approx. 0.7% of cancer deaths yearly. As of 2011, there were approximately 250,000 women living with cervical cancer in the United States. Those diagnosed with cervical cancer have a 5 year survival rate of 67.9%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.2% and 1.3% per year, respectively. Biocare Medical is proud to offer key cervical antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Cervix Uteri Cancer. National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/statfacts/html/cervix.html